{"id":37565,"date":"2020-08-12T10:58:13","date_gmt":"2020-08-12T14:58:13","guid":{"rendered":"https:\/\/www.arisglobal.com\/?p=37565"},"modified":"2020-08-12T10:58:13","modified_gmt":"2020-08-12T14:58:13","slug":"digitally-transforming-pharmacovigilance-processes-requires-a-careful-balance-between-technology-economics-and-humanity","status":"publish","type":"post","link":"https:\/\/www.arisglobal.com\/blogs\/digitally-transforming-pharmacovigilance-processes-requires-a-careful-balance-between-technology-economics-and-humanity\/","title":{"rendered":"Best Practices for Digitally Transforming Pharmacovigilance Processes"},"content":{"rendered":"\n

On June 9th, 2020<\/span>\u00a0ArisGlobal held a webinar titled<\/span> \u201c<\/span>Pharmacovigilance and Digital Transformation: Stepping into the Technology-Driven Future.\u201d<\/span><\/b><\/a>\u00a0<\/span><\/b>During the webinar, over half (58%) of attendees indicated that they are no longer relying on Microsoft Excel workbooks to manage case activities such as allocation, workflow management and query tracking. ArisGlobal has noted a continuous trend away from manual processes. On October 15th\u00a0of 2019, for example, during\u00a0ArisGlobal\u2019s<\/span>,<\/span>\u00a0<\/span>\u201c<\/span><\/i>Automation in Pharmacovigilance: From Hype to Realit<\/span><\/i><\/b>y<\/span><\/i><\/b><\/a>\u201d\u00a0<\/span><\/i>webinar, nearly half (43%) of all respondents considered automation of pharmacovigilance (PV) processes to be a top priority for their organizations.\u202f<\/i><\/span>\u00a0<\/span><\/p>\n

Key Barriers to Adopting Next-Gen Technologies in Pharmacovigilance<\/h2>\n

The webinar, presented\u00a0by\u202fAman\u00a0Wasan<\/a>,\u00a0Senior\u00a0Vice President, Global Pharmacovigilance for ArisGlobal\u00a0explored\u00a0the perceived\u00a0barriers\u00a0toward\u00a0adopting next-generation technologies in PV<\/a>.\u00a0The responses\u00a0were varied,\u00a0with budget\u00a0being the biggest reason at\u00a0thirty-eight percent (38%), followed by resistance to change at twenty-eight percent (28%), expertise at twenty-two percent (22%), and only twelve percent (12%) of the respondents believed it is awareness.<\/span><\/p>\n

Key Considerations for Adopting Next-Gen PV Technologies<\/h2>\n

ArisGlobal believes that adopting next-generation technologies to support pharmacovigilance processes requires a careful balance between technology, economics, and humanity. It is no surprise to see budgetary concerns as the top barrier toward adoption. Technology requires investment and that investment must be done carefully. However, it is interesting to see the human side of technology adoption, \u201cresistance to change\u201d as the second highest concern.\u00a0\u00a0Ultimately, digital transformation strongly transforms people\u2019s day-to-day processes. If companies recognize this and address it properly, such as with thoughtful training, they can adopt technology in a faster, more seamless, and expedited way.\u00a0<\/span><\/p>\n

ArisGlobal\u2019s\u00a0LifeSphere MultiVigilance\u00a010<\/a>\u00a0is the only automated, end-to-end safety system built with the industry, for the industry, and developed in partnership with the world\u2019s best life sciences companies.\u00a0Contact us<\/a>\u00a0today to find out how LifeSphere Multivigilance 10 can help your Pharmacovigilance team, or visit our\u00a0product page<\/a>.\u00a0<\/span><\/p>\n

To\u00a0learn more about the questions highlighted in this blog series, view the on-demand webinar\u00a0Pharmacovigilance and Digital Transformation: Stepping into the Technology-Driven Future<\/i><\/b>.<\/a>\u00a0<\/span><\/span><\/p>\n

To find out\u00a0more\u00a0about\u00a0how LifeSphere Multivigilance helps SMBs manage and master pharmacovigilance, read our blog\u00a0here<\/a>.\u00a0<\/span><\/p>\n

(This is Blog\u00a0<\/i>#<\/i>2<\/i>\u00a0<\/i>in a\u00a0<\/i>two-part\u00a0<\/i>series from the\u00a0<\/i>Pharmacovigilance and Digital Transformation: Stepping into the Technology-Driven Future\u00a0<\/i><\/b>webinar.)<\/i>\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":27,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[67],"tags":[83],"class_list":["post-37565","post","type-post","status-publish","format-standard","hentry","category-blogs","tag-arisglobal-blogs"],"acf":[],"yoast_head":"\nBest Practices for Digitally Transforming Pharmacovigilance Processes<\/title>\n<meta name=\"description\" content=\"Find best practices for how to use technology to maximize pharmacovigilance practices and results. Learn more here.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.arisglobal.com\/blogs\/digitally-transforming-pharmacovigilance-processes-requires-a-careful-balance-between-technology-economics-and-humanity\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Best Practices for Digitally Transforming Pharmacovigilance Processes\" \/>\n<meta property=\"og:description\" content=\"Find best practices for how to use technology to maximize pharmacovigilance practices and results. Learn more here.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.arisglobal.com\/blogs\/digitally-transforming-pharmacovigilance-processes-requires-a-careful-balance-between-technology-economics-and-humanity\/\" \/>\n<meta property=\"og:site_name\" content=\"ArisGlobal\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LifeSphereAG\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-08-12T14:58:13+00:00\" \/>\n<meta name=\"author\" content=\"Mladen Prenc\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mladen Prenc\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.arisglobal.com\/blogs\/digitally-transforming-pharmacovigilance-processes-requires-a-careful-balance-between-technology-economics-and-humanity\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.arisglobal.com\/blogs\/digitally-transforming-pharmacovigilance-processes-requires-a-careful-balance-between-technology-economics-and-humanity\/\"},\"author\":{\"name\":\"Mladen Prenc\",\"@id\":\"https:\/\/www.arisglobal.com\/#\/schema\/person\/bb2c7aafe44a090bcd667448651eb974\"},\"headline\":\"Best Practices for Digitally Transforming Pharmacovigilance Processes\",\"datePublished\":\"2020-08-12T14:58:13+00:00\",\"dateModified\":\"2020-08-12T14:58:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.arisglobal.com\/blogs\/digitally-transforming-pharmacovigilance-processes-requires-a-careful-balance-between-technology-economics-and-humanity\/\"},\"wordCount\":382,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.arisglobal.com\/#organization\"},\"keywords\":[\"ArisGlobal Blogs\"],\"articleSection\":[\"Blog\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.arisglobal.com\/blogs\/digitally-transforming-pharmacovigilance-processes-requires-a-careful-balance-between-technology-economics-and-humanity\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.arisglobal.com\/blogs\/digitally-transforming-pharmacovigilance-processes-requires-a-careful-balance-between-technology-economics-and-humanity\/\",\"url\":\"https:\/\/www.arisglobal.com\/blogs\/digitally-transforming-pharmacovigilance-processes-requires-a-careful-balance-between-technology-economics-and-humanity\/\",\"name\":\"Best Practices for Digitally Transforming Pharmacovigilance Processes\",\"isPartOf\":{\"@id\":\"https:\/\/www.arisglobal.com\/#website\"},\"datePublished\":\"2020-08-12T14:58:13+00:00\",\"dateModified\":\"2020-08-12T14:58:13+00:00\",\"description\":\"Find best practices for how to use technology to maximize pharmacovigilance practices and results. Learn more here.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.arisglobal.com\/blogs\/digitally-transforming-pharmacovigilance-processes-requires-a-careful-balance-between-technology-economics-and-humanity\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.arisglobal.com\/blogs\/digitally-transforming-pharmacovigilance-processes-requires-a-careful-balance-between-technology-economics-and-humanity\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.arisglobal.com\/blogs\/digitally-transforming-pharmacovigilance-processes-requires-a-careful-balance-between-technology-economics-and-humanity\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.arisglobal.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Best Practices for Digitally Transforming Pharmacovigilance Processes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.arisglobal.com\/#website\",\"url\":\"https:\/\/www.arisglobal.com\/\",\"name\":\"ArisGlobal\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.arisglobal.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.arisglobal.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.arisglobal.com\/#organization\",\"name\":\"LifeSphere\",\"url\":\"https:\/\/www.arisglobal.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.arisglobal.com\/#\/schema\/logo\/image\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"LifeSphere\"},\"image\":{\"@id\":\"https:\/\/www.arisglobal.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/LifeSphereAG\/\",\"https:\/\/www.linkedin.com\/products\/aris-global-lifesphere\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.arisglobal.com\/#\/schema\/person\/bb2c7aafe44a090bcd667448651eb974\",\"name\":\"Mladen Prenc\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Best Practices for Digitally Transforming Pharmacovigilance Processes","description":"Find best practices for how to use technology to maximize pharmacovigilance practices and results. Learn more here.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.arisglobal.com\/blogs\/digitally-transforming-pharmacovigilance-processes-requires-a-careful-balance-between-technology-economics-and-humanity\/","og_locale":"en_US","og_type":"article","og_title":"Best Practices for Digitally Transforming Pharmacovigilance Processes","og_description":"Find best practices for how to use technology to maximize pharmacovigilance practices and results. Learn more here.","og_url":"https:\/\/www.arisglobal.com\/blogs\/digitally-transforming-pharmacovigilance-processes-requires-a-careful-balance-between-technology-economics-and-humanity\/","og_site_name":"ArisGlobal","article_publisher":"https:\/\/www.facebook.com\/LifeSphereAG\/","article_published_time":"2020-08-12T14:58:13+00:00","author":"Mladen Prenc","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Mladen Prenc","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.arisglobal.com\/blogs\/digitally-transforming-pharmacovigilance-processes-requires-a-careful-balance-between-technology-economics-and-humanity\/#article","isPartOf":{"@id":"https:\/\/www.arisglobal.com\/blogs\/digitally-transforming-pharmacovigilance-processes-requires-a-careful-balance-between-technology-economics-and-humanity\/"},"author":{"name":"Mladen Prenc","@id":"https:\/\/www.arisglobal.com\/#\/schema\/person\/bb2c7aafe44a090bcd667448651eb974"},"headline":"Best Practices for Digitally Transforming Pharmacovigilance Processes","datePublished":"2020-08-12T14:58:13+00:00","dateModified":"2020-08-12T14:58:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.arisglobal.com\/blogs\/digitally-transforming-pharmacovigilance-processes-requires-a-careful-balance-between-technology-economics-and-humanity\/"},"wordCount":382,"commentCount":0,"publisher":{"@id":"https:\/\/www.arisglobal.com\/#organization"},"keywords":["ArisGlobal Blogs"],"articleSection":["Blog"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.arisglobal.com\/blogs\/digitally-transforming-pharmacovigilance-processes-requires-a-careful-balance-between-technology-economics-and-humanity\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.arisglobal.com\/blogs\/digitally-transforming-pharmacovigilance-processes-requires-a-careful-balance-between-technology-economics-and-humanity\/","url":"https:\/\/www.arisglobal.com\/blogs\/digitally-transforming-pharmacovigilance-processes-requires-a-careful-balance-between-technology-economics-and-humanity\/","name":"Best Practices for Digitally Transforming Pharmacovigilance Processes","isPartOf":{"@id":"https:\/\/www.arisglobal.com\/#website"},"datePublished":"2020-08-12T14:58:13+00:00","dateModified":"2020-08-12T14:58:13+00:00","description":"Find best practices for how to use technology to maximize pharmacovigilance practices and results. Learn more here.","breadcrumb":{"@id":"https:\/\/www.arisglobal.com\/blogs\/digitally-transforming-pharmacovigilance-processes-requires-a-careful-balance-between-technology-economics-and-humanity\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.arisglobal.com\/blogs\/digitally-transforming-pharmacovigilance-processes-requires-a-careful-balance-between-technology-economics-and-humanity\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.arisglobal.com\/blogs\/digitally-transforming-pharmacovigilance-processes-requires-a-careful-balance-between-technology-economics-and-humanity\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.arisglobal.com\/"},{"@type":"ListItem","position":2,"name":"Best Practices for Digitally Transforming Pharmacovigilance Processes"}]},{"@type":"WebSite","@id":"https:\/\/www.arisglobal.com\/#website","url":"https:\/\/www.arisglobal.com\/","name":"ArisGlobal","description":"","publisher":{"@id":"https:\/\/www.arisglobal.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.arisglobal.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.arisglobal.com\/#organization","name":"LifeSphere","url":"https:\/\/www.arisglobal.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.arisglobal.com\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"LifeSphere"},"image":{"@id":"https:\/\/www.arisglobal.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/LifeSphereAG\/","https:\/\/www.linkedin.com\/products\/aris-global-lifesphere\/"]},{"@type":"Person","@id":"https:\/\/www.arisglobal.com\/#\/schema\/person\/bb2c7aafe44a090bcd667448651eb974","name":"Mladen Prenc"}]}},"_links":{"self":[{"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/posts\/37565"}],"collection":[{"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/comments?post=37565"}],"version-history":[{"count":0,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/posts\/37565\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/media?parent=37565"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/categories?post=37565"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/tags?post=37565"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}